BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh V, Kesharwani P. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics. J Biomater Sci Polym Ed 2021;:1-28. [PMID: 34078252 DOI: 10.1080/09205063.2021.1938859] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Szota M, Wolski P, Carucci C, Marincola FC, Gurgul J, Panczyk T, Salis A, Jachimska B. Effect of Ionization Degree of Poly(amidoamine) Dendrimer and 5-Fluorouracil on the Efficiency of Complex Formation-A Theoretical and Experimental Approach. Int J Mol Sci 2023;24. [PMID: 36614260 DOI: 10.3390/ijms24010819] [Reference Citation Analysis]
2 Dey A, Singhvi G, Puri A, Kesharwani P, Dubey SK. Challenges, conclusions, and future aspects of photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00015-3] [Reference Citation Analysis]
3 Lee SY, Chae CH, Zrínyi M, Che X, Choi JY, Cho DH. Characterization of a conjugated polysuccinimide-carboplatin compound. Korean J Physiol Pharmacol 2023;27:31-8. [PMID: 36575931 DOI: 10.4196/kjpp.2023.27.1.31] [Reference Citation Analysis]
4 Kesharwani P, Chadar R, Shukla R, Jain GK, Aggarwal G, Abourehab MAS, Sahebkar A. Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics. J Biomater Sci Polym Ed 2022;33:2433-71. [PMID: 35848467 DOI: 10.1080/09205063.2022.2103627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chen Y, Shi S, Dai Y. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy. Biomedicine & Pharmacotherapy 2022;156:113903. [DOI: 10.1016/j.biopha.2022.113903] [Reference Citation Analysis]
6 Soltani A, Faramarzi M, Farjadian F, Parsa SAM, Panahi HA. pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery. Int J Biol Macromol 2022;221:508-22. [PMID: 36089082 DOI: 10.1016/j.ijbiomac.2022.09.037] [Reference Citation Analysis]
7 Rehman U, Parveen N, Sheikh A, Abourehab MAS, Sahebkar A, Kesharwani P. Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer. Colloids Surf B Biointerfaces 2022;218:112766. [PMID: 35994990 DOI: 10.1016/j.colsurfb.2022.112766] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kaya S, Kondolot Solak E. Development of ketorolac tromethamine loaded biocompatible polymeric microspheres and matrix films: designing for topical application. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2022.2097679] [Reference Citation Analysis]
9 Li X, Naeem A, Xiao S, Hu L, Zhang J, Zheng Q. Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine. Pharmaceutics 2022;14:1292. [PMID: 35745863 DOI: 10.3390/pharmaceutics14061292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Ahmad I, Khan MFA, Rahdar A, Hussain S, Tareen FK, Salim MW, Ajalli N, Amirzada MI, Khan A. Design and Evaluation of pH Sensitive PEG-Protamine Nanocomplex of Doxorubicin for Treatment of Breast Cancer. Polymers (Basel) 2022;14:2403. [PMID: 35745979 DOI: 10.3390/polym14122403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kumar Dubey S, Dabholkar N, Narayan Pal U, Singhvi G, Kumar Sharma N, Puri A, Kesharwani P. Emerging innovations in cold plasma therapy against cancer: a paradigm shift. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.05.014] [Reference Citation Analysis]
12 Dennahy IS, Han Z, Maccuaig WM, Chalfant HM, Condacse A, Hagood JM, Claros-sorto JC, Razaq W, Holter-chakrabarty J, Squires R, Edil BH, Jain A, Mcnally LR. Nanotheranostics for Image-Guided Cancer Treatment. Pharmaceutics 2022;14:917. [DOI: 10.3390/pharmaceutics14050917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hu Q, Yao J, Wang X, Wang Y, Fu X, Ma J, Lin H, Xu J, Shen L, Yu X. Combinational Chemoimmunotherapy for Breast Cancer by Codelivery of Doxorubicin and PD-L1 siRNA Using a PAMAM-Incorporated Liposomal Nanoplatform. ACS Appl Mater Interfaces 2022;14:8782-92. [PMID: 35138103 DOI: 10.1021/acsami.1c21775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Nadaf A, Gupta A, Hasan N, Fauziya, Ahmad S, Kesharwani P, Ahmad FJ. Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Adv 2022;12:23808-28. [DOI: 10.1039/d2ra02864f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release 2021;337:589-611. [PMID: 34364919 DOI: 10.1016/j.jconrel.2021.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]